Ozempic vs Zepbound
Ozempic and Zepbound get compared constantly online, but they hold different labels and different ingredients. Ozempic is semaglutide, approved for type 2 diabetes. Zepbound is tirzepatide, approved for weight management and for obstructive sleep apnea in adults with obesity. This page puts the two side by side honestly: what each is for, how the schedules differ, what the ingredient level trial results do and do not show, and how the prices compare.
A diabetes pen against a weight pen
| Detail | Ozempic | Zepbound |
|---|---|---|
| Active ingredient | Semaglutide, a GLP-1 receptor agonist | Tirzepatide, which acts on both GIP and GLP-1 receptors |
| Approved for | Type 2 diabetes | Weight management, and obstructive sleep apnea in adults with obesity |
| How often | One injection, once a week | One injection, once a week |
| Max weekly dose | 2 mg | 15 mg maximum; label maintenance doses are 5 mg, 10 mg or 15 mg |
| Trial result (ingredient level) | Semaglutide at 2.4 mg averaged 14.9 percent weight loss over 68 weeks in STEP 1 | Tirzepatide at 15 mg averaged 20.9 percent weight loss over 72 weeks in SURMOUNT-1 |
| About list price per month | About $1,000 | About $1,060 |
Read the trial row with care. STEP 1 and SURMOUNT-1 studied these ingredients at their weight management doses, in separate trials with different groups of people over different lengths of time. They were not a head to head comparison, and both medicines on this page earned their diabetes approvals in blood sugar trials, not weight trials.
How they differ in practice
Start with the jobs. Ozempic is prescribed to control blood sugar in type 2 diabetes, and its schedule starts at 0.25 mg with optional increases to a 2 mg maximum, driven by blood sugar results. Zepbound is prescribed for weight management, starts at 2.5 mg, climbs in 2.5 mg steps, and settles on a maintenance dose chosen from 5, 10 or 15 mg. The ingredients differ as well: semaglutide acts on the GLP-1 receptor, while tirzepatide acts on GIP and GLP-1 receptors, and the milligram scales of the two schedules are not comparable. The Ozempic dosage chart and the Zepbound dosage chart show both schedules in full.
The pair gets compared online because both are weekly injections discussed in weight conversations. On paper, though, they answer to different labels, and that shapes everything from who is prescribed which, to which one an insurer will pay for.
Side effects compared
The labels share the same core profile: nausea, vomiting, diarrhea and constipation lead both lists, most often while doses are climbing, alongside the same family of serious warnings. Neither label can predict which medicine an individual will tolerate better. The Ozempic side effects page and the Zepbound side effects page go through each profile in plain language.
Who each is usually prescribed for
Ozempic is for adults with type 2 diabetes. Zepbound is for weight management in people who meet its label criteria, and for obstructive sleep apnea in adults with obesity. A person with diabetes whose main goal is weight will usually be steered by their prescriber toward the labels that match the treatment plan, and tirzepatide's diabetes label is Mounjaro, not Zepbound. Coverage follows the label in most plans, which is often the practical deciding factor.
Switching between them
Moving from Ozempic to Zepbound means changing both the ingredient and the treatment goal at once, so it needs a proper conversation rather than a simple swap. It is always a prescriber decision, never a self switch. Your prescriber will confirm that the weight management label fits your situation, set the starting point on the Zepbound schedule, time the changeover, and make sure blood sugar stays monitored if diabetes is part of your picture. Never overlap the two pens.
Frequently asked questions
Can Zepbound replace Ozempic for diabetes?
No. Zepbound's label is weight management and obstructive sleep apnea, not diabetes. The tirzepatide product approved for type 2 diabetes is Mounjaro, which uses the same ingredient and dose steps. If diabetes control is the goal, that is the label your prescriber will work from.
Why do people compare Ozempic and Zepbound?
Both are once weekly injections that appear in the same weight loss conversations, and Ozempic became widely known partly through weight stories even though its label is diabetes. The comparison is understandable, but the labels matter: they decide who each pen is for and what insurance will cover.
Which is cheaper, Ozempic or Zepbound?
They are close at list price: about $1,000 a month for Ozempic and about $1,060 for Zepbound. The real difference is coverage. Diabetes coverage and weight management coverage sit in different parts of most insurance plans, so the pen that matches your treatment goal is usually the cheaper one in practice.
Is Zepbound stronger than Ozempic?
Stronger is not a label claim, and the numbers cannot be lined up that way. The ingredient level weight figures, 14.9 percent in STEP 1 and 20.9 percent in SURMOUNT-1, come from separate trials in different people over different durations, and neither trial tested these two products against each other. The milligram scales, 2 mg against 15 mg, are also not comparable across ingredients.
Can I switch from Ozempic to Zepbound?
It can happen when a prescriber agrees the weight management label fits your goals, but it is a prescriber decision, never a self switch. Two things change at once, the ingredient and the approved purpose, so your prescriber will set the new schedule, time the changeover, and keep blood sugar monitored if you have diabetes. Never take both pens in the same week.